{"id":"https://openalex.org/W2287123786","doi":null,"title":"[Pharmacological strategies to improve the adherence to highly active antiretroviral therapy].","display_name":"[Pharmacological strategies to improve the adherence to highly active antiretroviral therapy].","publication_year":2013,"publication_date":"2013-03-01","ids":{"openalex":"https://openalex.org/W2287123786","mag":"2287123786","pmid":"https://pubmed.ncbi.nlm.nih.gov/23693110"},"language":"es","primary_location":{"id":"pmid:23693110","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23693110","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista medica del Instituto Mexicano del Seguro Social","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061109041","display_name":"Oneyda Clap\u00e9 Laffita","orcid":"https://orcid.org/0000-0002-8069-705X","observed_orcids":["https://orcid.org/0000-0002-8069-705X","https://orcid.org/0009-0004-8982-3966"]},"institutions":[{"id":"https://openalex.org/I4405256666","display_name":"Centro de Toxicolog\u00eda y Biomedicina","ror":"https://ror.org/04dq4wh71","country_code":"CU","type":"facility","lineage":["https://openalex.org/I4405256666"]},{"id":"https://openalex.org/I4405260582","display_name":"Universidad de Ciencias M\u00e9dicas de Santiago de Cuba","ror":"https://ror.org/03zp9tj36","country_code":"CU","type":"education","lineage":["https://openalex.org/I4405260582"]}],"countries":["CU"],"is_corresponding":true,"raw_author_name":"Oneyda Clap\u00e9-Laffita","raw_affiliation_strings":["Centro de Toxicolog\u00eda y Biomedicina, Universidad de Ciencias M\u00e9dicas, Santiago de Cuba, Cuba. oneyda.clape@medired.scu.sld.cu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Toxicolog\u00eda y Biomedicina, Universidad de Ciencias M\u00e9dicas, Santiago de Cuba, Cuba. oneyda.clape@medired.scu.sld.cu","institution_ids":["https://openalex.org/I4405256666","https://openalex.org/I4405260582"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5061109041"],"corresponding_institution_ids":["https://openalex.org/I4405256666","https://openalex.org/I4405260582"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"51","issue":"2","first_page":"200","last_page":"3"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.6723999977111816,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.6723999977111816,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.3149000108242035,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiretroviral-therapy-adherence","display_name":"antiretroviral therapy adherence","score":0.949999988079071},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.9309999942779541},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.796999990940094},{"id":"https://openalex.org/keywords/pharmacokinetic-monitoring","display_name":"pharmacokinetic monitoring","score":0.8180000185966492},{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":0.8740000128746033},{"id":"https://openalex.org/keywords/nevirapine","display_name":"nevirapine","score":0.996999979019165},{"id":"https://openalex.org/keywords/zidovudine","display_name":"zidovudine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9480000138282776},{"id":"https://openalex.org/keywords/antiretroviral-therapy-adverse-effects","display_name":"antiretroviral therapy adverse effects","score":0.9020000100135803},{"id":"https://openalex.org/keywords/fluconazole","display_name":"fluconazole","score":0.9700000286102295},{"id":"https://openalex.org/keywords/ketoconazole","display_name":"ketoconazole","score":0.9150000214576721},{"id":"https://openalex.org/keywords/namibia","display_name":"Namibia","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.9196828603744507},{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.8712900876998901},{"id":"https://openalex.org/C2779889181","wikidata":"https://www.wikidata.org/wiki/Q423984","display_name":"Stavudine","level":5,"score":0.8482037782669067},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.8069384098052979},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6385302543640137},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.627326250076294},{"id":"https://openalex.org/C2777210460","wikidata":"https://www.wikidata.org/wiki/Q425490","display_name":"Indinavir","level":5,"score":0.5498615503311157},{"id":"https://openalex.org/C2780216070","wikidata":"https://www.wikidata.org/wiki/Q198504","display_name":"Zidovudine","level":4,"score":0.4824115037918091},{"id":"https://openalex.org/C3019165603","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral treatment","level":5,"score":0.4568302631378174},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.44477084279060364},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4283534288406372},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.401228129863739},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2201663851737976},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.16250887513160706},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.14984720945358276},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.07992669939994812},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.06553694605827332}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:23693110","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23693110","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista medica del Instituto Mexicano del Seguro Social","raw_type":"Journal Article"},{"id":"pmh:oai:redalyc.org:457745488016","doi":null,"is_oa":false,"landing_page_url":"https://www.redalyc.org/articulo.oa?id=457745488016","pdf_url":null,"source":{"id":"https://openalex.org/S4377196100","display_name":"Redalyc (Universidad Aut\u00f3noma del Estado de M\u00e9xico)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I179647637","host_organization_name":"Universidad Aut\u00f3noma del Estado de M\u00e9xico","host_organization_lineage":["https://openalex.org/I179647637"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Revista M\u00e9dica del Instituto Mexicano del Seguro Social (M\u00e9xico) Num.2 Vol.51","raw_type":"art\u00edculo cient\u00edfico"},{"id":"mag:2287123786","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23693110","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7037681512","https://openalex.org/W1996235673","https://openalex.org/W2572063907","https://openalex.org/W2107996551","https://openalex.org/W2918612337","https://openalex.org/W2015896206","https://openalex.org/W2619640992","https://openalex.org/W2015199696","https://openalex.org/W2013644457","https://openalex.org/W2474270538"],"abstract_inverted_index":{"BACKGROUND:":[0],"adherence":[1,30,124],"to":[2,18,31,125,140],"antiretroviral":[3,32,58,128],"therapy":[4,59,129],"is":[5],"an":[6],"important":[7],"factor":[8],"in":[9,24,43,60],"achieving":[10],"human":[11,45],"immunodeficiency":[12,46],"virus":[13,47],"suppression.":[14],"The":[15],"aim":[16],"was":[17,130],"apply":[19],"a":[20,37],"pharmacological":[21,138],"strategy,":[22],"based":[23],"pharmacokinetics":[25,108],"measures":[26,109],"for":[27,40,55,89,93,100],"improving":[28],"the":[29,123,133,136],"therapy.":[33],"METHODS:":[34],"We":[35],"did":[36],"descriptive":[38],"study":[39],"eight":[41],"months":[42],"75":[44],"positive":[48],"patients":[49],"with":[50,110,132],"clinical":[51],"and":[52,70,91,95,113,115,118,144],"social":[53],"criteria":[54],"highly":[56,126],"active":[57,127],"Opuwo,":[61],"Namibia.":[62],"Pharmacological":[63],"aspects,":[64],"such":[65],"as":[66],"major":[67,97],"side":[68,84,98,142],"effects":[69,85,143],"dangerous":[71,145],"drug-drug":[72],"interactions,":[73],"were":[74,79,86,105],"evaluated.":[75],"Descriptive":[76],"statistics":[77],"analysis":[78],"applied.":[80],"RESULTS:":[81],"three":[82],"minor":[83],"detected":[87],"(two":[88],"efavirenz":[90],"one":[92,96],"nevirapine),":[94],"effect":[99],"stavudine/lamivudine.":[101],"Dangerous":[102],"drug":[103,146],"interactions":[104],"avoided":[106],"doing":[107],"efavirenz,":[111],"stavudine/lamivudine":[112],"zidovudine;":[114],"between":[116],"nevirapine":[117],"fluconazol":[119],"or":[120],"ketoconazol.":[121],"CONCLUSIONS:":[122],"improved":[131],"application":[134],"of":[135],"proposed":[137],"strategy":[139],"avoid":[141],"interactions.":[147]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}